{"id":15855,"date":"2025-12-16T11:28:08","date_gmt":"2025-12-16T05:58:08","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=15855"},"modified":"2025-12-16T11:46:22","modified_gmt":"2025-12-16T06:16:22","slug":"stocks-to-buy-today-december-16-2025","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-december-16-2025\/","title":{"rendered":"Stocks to Buy Today: December 16, 2025"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]Indian equity markets entered Tuesday\u2019s session on a cautious footing after snapping a two-day winning streak. On Monday, benchmark indices ended marginally lower amid weak global cues and continued foreign fund outflows. The Sensex<\/a> slipped 54.30 points, or 0.06%, to close at 85,213, while the Nifty 50<\/a> declined 19.65 points, or 0.08%, to 26,027.30.<\/p>\n

The Nifty faced resistance near the 26,050 zone before closing slightly lower, indicating a pause after recent gains. Currency movements are also adding to market caution. The Indian rupee weakened further, settling at a fresh all-time low of 90.74 against the US dollar, after touching 90.80 during intraday trade. Analysts attribute the pressure to delays in the India-US trade deal, sustained FII selling, and a higher import bill due to elevated gold and silver prices. Near term, the rupee is expected to trade in the 90.00 to 91.25 range.<\/p>\n

The primary market remains active, with the \u20b9710 crore KSH International IPO<\/a> opening today and ICICI Prudential AMC IPO<\/a> entering its final day of bidding. Against this mixed backdrop of global uncertainty, currency volatility, and selective domestic triggers, stock-specific opportunities continue to emerge.<\/p>\n

Here are three stocks that investors may track closely in today\u2019s trading session.<\/p>\n

<\/span>Tata Chemicals Ltd. (NSE: TATACHEM)<\/strong><\/span><\/h2>\n

Tata Chemicals<\/a> has been in focus this week as the stock approaches key technical levels after a modest correction. The company closed the previous week down nearly 2%, reflecting near-term profit booking. From a technical perspective, the stock is trading within a defined range, offering a clear risk-reward setup for traders.<\/p>\n

Immediate support for Tata Chemicals lies around \u20b9744, with stronger support seen near \u20b9729. On the upside, resistance is placed near \u20b9776. A sustained move above this level could trigger a sharp breakout towards \u20b9794 and higher in the near term. The broader trading range for the week is seen between \u20b9712 on the downside and \u20b9808 on the upside.<\/p>\n

The stock is being recommended for its well-defined technical structure and proximity to resistance. Any decisive close above \u20b9776 could attract momentum-based buying, while strong support levels help limit downside risk for short-term traders.<\/p>\n

<\/span>Key stock details:<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nDetails <\/strong><\/td>\n<\/tr>\n<\/thead>\n
Previous Close (as of Dec 15, 2025)<\/td>\n\u20b9765.90<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b9763.70 \u2013 \u20b9770.40<\/td>\n<\/tr>\n
Market Capitalisation<\/td>\n\u20b919,603 crore<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n332.58K<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n81.58<\/td>\n<\/tr>\n
52 Week High<\/td>\n\u20b91,107.00<\/td>\n<\/tr>\n
52 Week Low<\/td>\n\u20b9747.00<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n1.43%<\/td>\n<\/tr>\n
Company Type<\/td>\nMid-cap stock<\/a><\/td>\n<\/tr>\n
Beta<\/td>\n1.04<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Krishna Institute of Medical Sciences Ltd. (NSE: KIMS)<\/strong><\/span><\/h2>\n

Krishna Institute of Medical Sciences<\/a> is in focus following a key operational development. The company has commenced operations at its new 350-bed multi-speciality hospital in Electronic City, Bengaluru, through its subsidiary KIMS Hospital Bengaluru Private Limited, with operations starting on December 15, 2025.<\/p>\n

This expansion strengthens KIMS\u2019 presence in Bengaluru and deepens its footprint in South India\u2019s healthcare market. The new facility offers advanced services across cardiac care, neurology, oncology, organ transplants, and robotic surgeries, positioning it well to cater to the growing healthcare demand in the region.<\/p>\n

From an investment perspective, the stock reflects a balance between near-term margin pressure and long-term growth visibility. While recent quarters have seen some pressure due to the ramp-up of new hospitals, management expects newly commissioned facilities to reach EBITDA<\/a> breakeven within the next 12 months. The addition of the Bengaluru hospital enhances long-term revenue potential and supports the company\u2019s expansion strategy.<\/p>\n

<\/span>Key stock details:<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nDetails<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Previous Close (as of Dec 15, 2025)<\/td>\n\u20b9670.10<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b9665.10 \u2013 \u20b9673.35<\/td>\n<\/tr>\n
Market Capitalisation<\/td>\n\u20b926,769 crore<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n331.39K<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n79.70<\/td>\n<\/tr>\n
52 Week High<\/td>\n\u20b9798.40<\/td>\n<\/tr>\n
52 Week Low<\/td>\n\u20b9474.05<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n–<\/td>\n<\/tr>\n
Company Type<\/td>\nMid-cap<\/td>\n<\/tr>\n
Beta<\/td>\n0.86<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Chambal Fertilisers and Chemicals Ltd. (NSE: CHAMBLFERT)<\/strong><\/span><\/h2>\n

Chambal Fertilisers<\/a> continues to stand out on strong fundamentals and improving capital efficiency. The company has consistently delivered a return on capital employed of around 20% over the past five years, well above the industry average. At the same time, capital employed has risen meaningfully, highlighting the company\u2019s ability to reinvest profitably.<\/p>\n

This combination of high ROCE and expanding capital base is a key reason the stock remains attractive from a medium to long-term perspective. Additionally, Chambal has reduced its reliance on current liabilities over the years, improving balance sheet quality and lowering financial risk.<\/p>\n

From a technical standpoint, the stock has strong support near \u20b9416, with immediate resistance placed around \u20b9445. A decisive move above this resistance could open the door for further upside towards \u20b9457. Given the favourable fundamentals, improving efficiency metrics, and a clearly defined technical setup, Chambal Fertilisers is worth tracking closely.<\/p>\n

<\/span>Key stock details:<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nDetails<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Previous Close (as of Dec 15, 2025)<\/td>\n\u20b9436.75<\/td>\n<\/tr>\n
Day Range<\/td>\n\u20b9436.50 \u2013 \u20b9455.50<\/td>\n<\/tr>\n
Market Capitalisation<\/td>\n\u20b918,201 crore<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n981.79K<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n9.76<\/td>\n<\/tr>\n
52 Week High<\/td>\n\u20b9742.20<\/td>\n<\/tr>\n
52 Week Low<\/td>\n\u20b9410.20<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n2.20%<\/td>\n<\/tr>\n
Company Type<\/td>\nMid-cap<\/td>\n<\/tr>\n
Beta<\/td>\n1.09<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Conclusion<\/strong><\/span><\/h2>\n

In a market environment marked by global uncertainty, currency volatility, and selective domestic triggers, stock-specific opportunities offer better risk-adjusted returns. Tata Chemicals presents a technical breakout opportunity near key resistance levels, Krishna Institute of Medical Sciences benefits from long-term growth visibility through capacity expansion, and Chambal Fertilisers stands out for its strong capital efficiency and reinvestment track record.<\/p>\n

Stock trading<\/a> does not guarantee returns. Investors should combine technical levels with fundamental strength, maintain strict risk management through stop losses, and align positions with their individual risk appetite and time horizon.<\/p>\n

If you are just beginning your investment journey, ensure you have a clear plan and adequate market access before taking positions.<\/p>\n

Just starting out? Begin your stock market<\/a> journey by opening a Demat Account<\/a> with Torus Digital today.[\/vc_column_text][vc_column_text css=””][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n